Métabolisme And NotW. R. W. Martin
List of bibliographic references
Number of relevant bibliographic references: 40.Ident. | Authors (with country if any) | Title |
---|---|---|
000179 | Megumi Shimizu [Japon] ; Yukihisa Suzuki [Japon] ; Motohiro Kiyosawa [Japon] ; Masato Wakakura [Japon] ; Kenji Ishii [Japon] ; Kiichi Ishiwata [Japon] ; Manabu Mochizuki [Japon] | Glucose Hypermetabolism in the Thalamus of Patients with Hemifacial Spasm |
000705 | Toru Baba [Japon] ; Atsushi Takeda [Japon] ; Akio Kikuchi [Japon] ; Yoshiyuki Nishio [Japon] ; Yoshiyuki Hosokai [Japon] ; Kazumi Hirayama [Japon] ; Takafumi Hasegawa [Japon] ; Naoto Sugeno [Japon] ; Kyoko Suzuki [Japon] ; Etsuro Mori [Japon] ; Shoki Takahashi [Japon] ; Hiroshi Fukuda [Japon] ; Yasuto Itoyama [Japon] | Association of Olfactory Dysfunction and Brain. Metabolism in Parkinson's Disease |
000730 | Catherine L. Gallagher [États-Unis] ; Bradley T. Christian [États-Unis] ; James E. Holden [États-Unis] ; Onofre T. Dejesus [États-Unis] ; Robert J. Nickles [États-Unis] ; Laura Buyan-Dent [États-Unis] ; Barbara B. Bendlin [États-Unis] ; Sandra J. Harding [États-Unis] ; Charles K. Stone [États-Unis] ; Barb Mueller [États-Unis] ; Sterling C. Johnson [États-Unis] | A Within-Subject Comparison of 6-[18F]Fluoro-m-tyrosine and 6-[18F]Fluoro-L-dopa in Parkinson's Disease |
000E13 | Shigeki Hirano [États-Unis] ; Thomas Eckert [États-Unis, Allemagne] ; Toni Flanagan [États-Unis] ; David Eidelberg [États-Unis] | Metabolic Networks for Assessment of Therapy and Diagnosis in Parkinson's Disease |
000F12 | Yoshiyuki Hosokai [Japon] ; Yoshiyuki Nishio [Japon] ; Kazumi Hirayama [Japon] ; Atsushi Takeda [Japon] ; Toshiyuki Ishioka [Japon] ; Yoichi Sawada [Japon] ; Kyoko Suzuki [Japon] ; Yasuto Itoyama [Japon] ; Shoki Takahashi [Japon] ; Hiroshi Fukuda [Japon] ; Etsuro Mori [Japon] | Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment |
001490 | Thomas Eckert [États-Unis, Allemagne] ; Andrew Feigin [États-Unis] ; Daniel E. Lewis [États-Unis] ; Vijay Dhawan [États-Unis] ; Steven Frucht [États-Unis] ; David Eidelberg [États-Unis] | Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging |
001819 | Michael Behen [États-Unis] ; Harry T. Chugani [États-Unis] ; Csaba Juhasz [États-Unis] ; Emily Helder [États-Unis] ; Albert Ho [États-Unis] ; Mohsin Maqbool [États-Unis] ; Robert D. Rothermel [États-Unis] ; Jacquie Perry [États-Unis] ; Otto Muzik [États-Unis] | Abnormal Brain Tryptophan Metabolism and Clinical Correlates in Tourette Syndrome |
001892 | Anna L. Bartels [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Nir Giladi [Israël] ; Joanna D. Schaafsma [Pays-Bas] ; R. Paul Maguire [Pays-Bas] ; Lammy Veenma [Pays-Bas] ; Jan Pruim [Pays-Bas] ; Yacov Balash [Israël] ; Moussa B. H. Youdim [Israël] ; Klaus L. Leenders [Pays-Bas] | Striatal dopa and glucose metabolism in PD patients with freezing of gait |
001A44 | Daniela Berg [Allemagne] ; Helmine Hochstrasser [Allemagne] | Iron metabolism in Parkinsonian syndromes |
001B37 | Stefanie Klaffke [Allemagne] ; Andrea A. Kuhn [Allemagne] ; Michail Plotkin [Allemagne] ; Holger Amthauer [Allemagne] ; Daniel Harnack [Allemagne] ; Roland Felix [Allemagne] ; Andreas Kupsch [Allemagne] | Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration |
001E78 | Reinoud C. Klein [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Joeke J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas] | Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease |
001F50 | Yoshihiro Sato [Japon] ; Yoshiaki Honda [Japon] ; Jun Iwamoto [Japon] ; Tomohiro Kanoko [Japon] ; Kei Satoh [Japon] | Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients |
002422 | David R. Lynch [États-Unis] ; P. David Mozley [États-Unis] ; Set Sokol [États-Unis] ; Nicole M. C. Maas [États-Unis] ; Laura J. Balcer [États-Unis] ; Andrew D. Siderowf [États-Unis] | Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease |
002425 | Ilse M. F. Coulier [Belgique] ; Joeke J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas] | Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration? |
002519 | Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications |
002915 | Georg Berding [Allemagne] ; Per Odin [Allemagne] ; David J. Brooks [Royaume-Uni] ; Guido Nikkhah [Allemagne] ; Cordula Matthies [Allemagne] ; Thomas Peschel [Allemagne] ; Mona Shing [Allemagne] ; Hans Kolbe [Allemagne] ; Jörg Van Den Hoff [Allemagne] ; Harald Fricke [Allemagne] ; Reinhard Dengler [Allemagne] ; Madjid Samii [Allemagne] ; Wolfram H. Knapp [Allemagne] | Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the Off and On conditions with [18F]FDG-PET |
002A79 | Gaetan Garraux [Belgique] ; Eric Salmon [Belgique] ; Philippe Peigneux [Belgique] ; Alexandre Kreisler [France] ; Christian Degueldre [Belgique] ; Christian Lemaire [Belgique] ; Alain Destée [France] ; Georges Franck [Belgique] | Voxel-based distribution of metabolic impairment in corticobasal degeneration |
002C77 | B. M. Ross [Canada] ; K. Eder [Allemagne] ; A. Moszczynska [Canada] ; N. Mamalias [Canada] ; J. Lamarche [Canada] ; LEE ANG [Canada] ; M. Pandolfo [Canada] ; G. Rouleau [Canada] ; M. Kirchgessner [Allemagne] ; S. J. Kish [Canada] | Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1 |
002D46 | C. Trenkwalder [Allemagne] ; A. S. Walters [États-Unis] ; W. A. Hening [États-Unis] ; S. Chokroverty [États-Unis] ; A. Antonini [États-Unis] ; V. Dhawan [États-Unis] ; D. Eidelberg [États-Unis] | Positron emission tomographic studies in restless legs syndrome |
002D49 | B. Barbiroli [Italie] ; P. Martinelli [Italie] ; A. Patuelli [Italie] ; R. Lodi [Italie] ; S. Iotti [Italie] ; P. Cortelli [Italie] ; P. Montagna [Italie] | Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease |
002E90 | A. Richter [Allemagne] ; J. M. Brotchie [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; W. Löscher [Allemagne] | [3H]-2-Deoxyglucose uptake study in mutant dystonic hamsters : Abnormalities in discrete brain regions of the motor system |
002F87 | E. C. Hirsch [France] ; B. A. Faucheux [France] | Iron metabolism and Parkinson's disease |
003014 | H. Boecker [Royaume-Uni, Allemagne] ; D. J. Brooks [Royaume-Uni] | Functional imaging of tremor |
003031 | R. Mielke [Allemagne] ; R. Hilker [Allemagne] ; G. Weber-Luxenburger [Allemagne] ; J. Kessler [Allemagne] ; W.-D. Heiss [Allemagne] | Early-onset cerebellar ataxia (EOCA) with retained reflexes : Reduced cerebellar benzodiazepine-receptor binding, progressive metabolic and cognitive impairment |
003039 | A. Antonini [États-Unis] ; K. Kazumata [États-Unis] ; A. Feigin [États-Unis] ; F. Mandel [États-Unis] ; V. Dhawan [États-Unis] ; C. Margouleff [États-Unis] ; D. Eidelberg [États-Unis] | Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET |
003075 | S. Dethy [Belgique] ; N. Van Blercom [Belgique] ; P. Damhaut [Belgique] ; D. Wikler [Belgique] ; J. Hildebrand [Belgique] ; S. Goldman [Belgique] | Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism |
003114 | C. E. Clarke [Royaume-Uni] ; M. Lowry [Royaume-Uni] ; A. Horsman [Royaume-Uni] | Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy |
003266 | S. Magyar-Lehmann [Suisse] ; A. Antonini [Suisse] ; U. Roelcke [Suisse] ; R. P. Maguire [Suisse] ; J. Missimer [Suisse] ; M. Meyer [Suisse] ; K. L. Leenders [Suisse] | Cerebral glucose metabolism in patients with spasmodic torticollis |
003267 | Y. Nagahama [Japon] ; H. Fukuyama [Japon] ; N. Turjanski [Royaume-Uni] ; A. Kennedy [Royaume-Uni] ; H. Yamauchi [Japon] ; Y. Ouchi [Japon] ; J. Kimura [Japon] ; D. J. Brooks [Royaume-Uni] ; H. Shibasaki [Japon] | Cerebral glucose metabolism in corticobasal degeneration : Comparison with progressive supranuclear palsy and normal controls |
003319 | C. Raftopoulos [Belgique] ; S. Dethy ; M. A. Laute ; S. Goldman ; A. B. Naini ; S. Przedborski ; J. Hildebrand | Slow increase of homovanillic acid in cerebrospinal fluid after levodopa administration |
003371 | D. S. Sax [États-Unis] ; R. Powsner [États-Unis] ; A. Kim [États-Unis] ; S. Tilak [États-Unis] ; R. Bhatia [États-Unis] ; L. A. Cupples [États-Unis] ; R. H. Myers [États-Unis] | Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography |
003482 | D. Smith [États-Unis] ; T. Ishikawa ; V. Dhawan ; J. S. Winterkorn ; D. Eidelberg [États-Unis] | Lid opening apraxia is associated with medial frontal hypometabolism |
003686 | E. Broussolle [France] ; L. Cinotti [France] ; Pierre Pollak [France] ; P. Landais [France] ; D. Le Bars [France] ; G. Galy [France] ; F. Lavenne [France] ; Y. Khalfallah ; G. Chazot [France] ; F. Mauguiere [France] | Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease |
003740 | T. Kuwert [Allemagne] ; J. Noth ; D. Scholz [Allemagne] ; M. Schwarz ; H. W. Lange ; R. Töpper ; H. Herzog [Allemagne] ; A. Aulich ; L. E. Feinendegen [Allemagne] | Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease |
003745 | S. Przedborski [Belgique] ; S. Goldman ; M. Levivier ; N. Giladi ; L. M. Bidaut ; J. Hildebrand [Belgique] ; E. Stanus ; D. Labar ; A. Luxen | Brain glucose metabolism and dopamine D2 receptor analysis in a patient with hemiparkinsonism-hemiatrophy syndrome |
003779 | I. J. Mitchell [Royaume-Uni] ; A. R. Crossman ; U. Liminga ; P. Andren ; L. M. Gunne | Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the cebus monkey |
003917 | D. Eidelberg ; J. R. Moeller ; V. Dhawan ; J. J. Sidtis ; J. Z. Ginos ; S. C. Strother ; J. Cedarbaum ; P. Greene ; S. Fahn ; D. A. Rottenberg | The metabolic anatomy of Parkinson's disease : complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies |
003A03 | R. M. Dubinsky ; M. Greenberg ; G. Di Chiro ; M. Baker ; M. Hallett | Hemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose |
003A30 | S. Rose ; P. Jenner ; C. D. Marsden | The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats |
003A72 | M. Guttman ; A. E. Lang ; E. S. Garnett ; C. Nahmias ; G. Firnau ; F. J. Tyndel ; A. S. Gordon | Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea |
This area was generated with Dilib version V0.6.23. |